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Abstract
Objective: This paper used data from a study of pediatric primary care provider (PCP) screening practices to
examine barriers to and facilitators of adolescent alcohol and other drug (AOD) screening in pediatric primary care.
Methods: A web-based survey (N = 437) was used to examine the influence of PCP factors (attitudes and
knowledge, training, self-efficacy, comfort with alcohol and drug issues); patient characteristics (age, gender,
ethnicity, comorbidities and risk factors); and organizational factors (screening barriers, staffing resources,
confidentiality issues) on AOD screening practices. Self-reported and electronic medical record (EMR)-recorded
screening rates were also assessed.
Results: More PCPs felt unprepared to diagnose alcohol abuse (42%) and other drug abuse (56%) than depression
(29%) (p < 0.001). Overall, PCPs were more likely to screen boys than girls, and male PCPs were even more likely
than female PCPs to screen boys (23% versus 6%, p < 0.0001). Having more time and having other staff screen and
review results were identified as potential screening facilitators. Self-reported screening rates were significantly
higher than actual (EMR-recorded) rates for all substances. Feeling prepared to diagnose AOD problems predicted
higher self-reported screening rates (OR = 1.02, p <0.001), and identifying time constraints as a barrier to screening
predicted lower self-reported screening rates (OR = 0.91, p < 0.001). Higher average panel age was a significant
predictor of increased EMR-recorded screening rates (OR = 1.11, p < 0.001).
Conclusions: Organizational factors, lack of training, and discomfort with AOD screening may impact adolescent
substance-abuse screening and intervention, but organizational approaches (e.g., EMR tools and workflow) may
matter more than PCP or patient factors in determining screening.
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Introduction
Alcohol and other drug (AOD) problems are major
causes of mortality and morbidity, and these problems
often begin in adolescence [1]. Pediatric primary care
providers (PCPs) are ideally placed to identify AOD pro-
blems in their adolescent patients and intervene before
the problems become more serious. Unfortunately, be-
havioral health fields have failed to persuade PCPs and
health systems to implement screening, brief interven-
tion, and referral to treatment (SBIRT) for adolescents
despite a mature body of evidence demonstrating the ef-
fectiveness of SBIRT for alcohol problems in adult pri-
mary care, and less robust but growing evidence
suggesting that brief intervention models of AOD ser-
vices are similarly effective for adolescents.
In this paper, we examine barriers to and facilitators of
AOD screening and intervention in pediatric primary
care using data from a study that examined pediatric
PCP practices and attitudes toward screening and treat-
ment for adolescent AOD use in a large integrated
health-care delivery system. The study’s intent was to in-
form the development of strategies to facilitate adoles-
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AOD use and adolescent health
Alcohol and other drug problems are a major cause of
morbidity and mortality among youth [2-4] and are a
significant public health problem. More common than
AOD disorders, however, and quite prevalent among
adolescent primary care patients, is less severe but still
risky AOD use. A survey of adolescent patients in a
pediatrics setting found prevalence rates for AOD abuse
to be 14.8% [5]. Adolescent AOD misuse co-occurs fre-
quently with mental health problems and other condi-
tions and behaviors that confer risk for unfavorable
health, delinquency, HIV [6], poor academic perform-
ance, and suicide [7]. Considered alongside emerging
evidence of the heightened vulnerability of the develop-
ing adolescent brain to the harmful effects of AOD use
[8,9], it seems clear that early identification and treat-
ment may prevent adverse long-term medical and men-
tal health outcomes.
Missed opportunities for problem identification in
pediatric primary care
Medical visits provide critical opportunities to detect
AOD problems [10], and PCPs may be especially effect-
ive agents to do so [11]. While many PCPs may worry
that patients do not wish to discuss AOD use during
check-ups, a recent national survey of teens and parents
actually found high receptivity to screening and inter-
vention by PCPs [12]. Brown and Wissow [13] found
that adolescents had more positive perceptions of care
when their PCP discussed “sensitive” topics with them,
including AOD use.
Although all adolescents with AOD problems may not
have access to or seek regular medical care, studies sug-
gest that these adolescents may be just as likely as those
without problems to visit a PCP [14]. Among adoles-
cents seeking AOD treatment in the health system in
which this study took place, 81% had a primary care visit
in the year before treatment, and 90% had one in the
two years prior to intake (unpublished observation, pre-
sented as “The role of primary care in addressing adoles-
cent substance use: screening, treatment, and
coordination” in Los Angeles on 6/22/07 at the California
Society of Addiction Medicine symposium: "Not Just
Small Adults: New Insights on Adolescent Brain Devel-
opment and Implications for Adolescent Substance
Abuse Treatment Conference"). In addition, AOD use is
often associated with other medical and mental health
problems. Adolescents with AOD problems have been
found to have more medical and psychiatric problems
than those without AOD problems [15,16], and, al-
though competing clinical priorities may reduce the like-
lihood of addressing AOD disorders, comorbidities may
also give providers an entree for discussing AOD use
with patients.
Adolescent AOD screening recommendations
Adolescent health experts have long called for more and
better AOD screening in pediatrics [17-19]. Several na-
tional organizations, including the US Preventive Ser-
vices Task Force, have developed clinical guidelines for
adolescent health care that specifically recommend
screening for AOD use. The American Academy of
Pediatrics’ Bright Futures and the American Medical
Association’s Guidelines for Adolescent Preventive Ser-
vices both recommend that youth aged 11 years and
older should be screened for AOD use at each annual
preventive health visit [20-23].
Suboptimal screening practices
Despite these recommendations relatively few PCPs
screen adolescents according to guidelines [24-26]. An
American Academy of Pediatrics’ survey found that only
45% of fellows routinely screened young patients for al-
cohol use, and only 16% reported using standardized
instruments [24]. There are many possible reasons for
these low levels of screening, including organizational
and systemic factors such as insufficient time and staff
resources [10], inadequate training in residency pro-
grams [27], concerns about intrusiveness or patient em-
barrassment [28,29], and low levels of self-efficacy and
confidence about discussing AOD use [30-32].
Research also suggests that, based on clinical impres-
sions alone, PCPs may fail to detect AOD problems
among adolescent patients. One study found that only
2% of the 16% of adolescents with diagnosed AOD disor-
ders were correctly identified by physicians as having a
substance-use problem [33]. Even when AOD screening
occurs, identification, intervention, and/or referral to
specialty care are not guaranteed. A study by Stevens
et al. [34] that screened adolescents for AOD disorders
in the waiting room found that doctors who received the
results prior to seeing the patient improved identifica-
tion significantly compared with those who received
results after the visit; however, they still failed to
recognize problems in 27% of the patients whose screen-
ing results indicated an AOD problem. In another study,
Hassan and colleagues [35] examined pediatricians’ per-
ceptions of the severity of patients’ AOD problems and
their practices with regard to follow-up interventions.
They found that, while 14% of the sample scored ≥2 on
the CRAFFT (Car, Relax, Alone, Forget, Friends,
Trouble) screening tool, indicating a likely AOD prob-
lem, providers’ diagnostic impressions led them to iden-
tify only 4.8% of the patients (N= 2034) with problem
use. Moreover, almost 20% of those perceived by the
providers to have an AOD problem still did not receive
a recommendation for an active intervention [35]. An-
other study of adolescents entering specialty AOD treat-
ment in a large health-care system found that fewer than
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20% of new patients were identified and referred to
treatment by their medical provider [16]. These findings
suggest that youth with AOD problems are not always
well-served by the health-care system or providers, and
that more work is needed to improve detection and
treatment.
SBIRT and adolescents
As a nationally recognized public health approach to
AOD problems, SBIRT is strongly supported by the Na-
tional Institute of Alcohol Abuse and Alcoholism
(NIAAA), the National Institute on Drug Abuse (NIDA),
and the Substance Abuse and Mental Health Services
Administration (SAMHSA), as well as by national med-
ical organizations including the American Academy of
Pediatrics [17]. A solid body of research developed over
the past two decades suggests that SBIRT is efficacious
for reducing risky AOD use in adolescents and that the
principles and techniques underlying SBIRT (e.g., motiv-
ational interviewing) may in fact be particularly well-
suited to the developmental stage of adolescence [36,37].
Several studies have demonstrated the efficacy [38-40],
effectiveness [41,42], and feasibility [43] of screening and
brief intervention for adolescents on a wide range of
outcomes, including reducing binge drinking, cannabis
use, drinking and driving, smoking, emergency depart-
ment use, and other harmful behaviors [36,38,40,44-53].
SBIRT in pediatric primary care
Research examining SBIRT for adolescents in pediatric
primary care settings has also shown promising results.
Ozer et al. [54] found that a brief alcohol intervention
by pediatric PCPs to 14- and 15-year-olds reduced risky
drinking [54]. De Micheli and colleagues [55] found that
a brief intervention delivered by pediatricians in an
adolescent primary care clinic resulted in a reduction in
use of several substances, including marijuana, alcohol,
inhalants, Ecstasy, and tobacco, in the intervention
group compared with controls who received no inter-
vention. Knight et al. [40] found promising results at
three months in a pilot study conducted partially in pri-
mary care, with an intervention delivered by both pedia-
tricians and nonphysicians; however the sample was
small, attrition was significant, and they did not examine
differences in effectiveness between the PCPs and non-
PCPs. D’Amico et al. [56] examined the impact of a brief
motivational intervention on AOD drug use for high-
risk teens in a primary care clinic and found decreased
use and increased self-efficacy at three months; however,
this pilot study also suffered from a small sample size
and low retention rates.
Factors influencing screening
The literature is well-established on provider skills and
attitudes, patient factors, and organizational factors that
influence screening and brief intervention practices.
These factors can be organized within a conceptual
framework of provider, patient, and organizational fac-
tors (Figure 1).
Primary care physicians may fail to screen for alcohol
use because of time constraints, lack of resources, lack
of training, unfamiliarity with screening instruments,
and attitudes toward particular health issues, including
estimation of risk [57-59]. In a recent survey, members
of the American Academy of Pediatrics reported the fol-
lowing barriers to providing services for child/adolescent
behavioral problems: lack of time (77%), lack of training
in treatment of such problems (65%), lack of confidence
in their ability to address problems (62%), and lack of
qualified specialty treatment providers to whom to refer
Figure 1 Provider, Patient, and Organizational Factors that Influence Screening and Brief Intervention Practices.
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patients (61%) [60]. A qualitative examination of barriers
specific to adolescent AOD screening ranked the bar-
riers as: 1) insufficient time, 2) lack of training to man-
age positive screens, 3) need to triage competing
medical problems, 4) lack of treatment resources, 5) and
“tenacious” parents who compromise confidentiality,
and 6) unfamiliarity with screening tools [61]. Many of
these barriers speak to increasing pressure on PCPs to
perform more services within shorter appointment
times.
That insufficient time is oft cited as a barrier to
screening reflects the pressures faced by today's PCPs.
Preventive health activities increase the average time
spent with patients [10]: one study estimated that for a
PCP to provide all the patients in a typical panel with all
the services recommended by the US Preventive Services
Task Force would require 7.4 hours per day [59].
Addressing behavioral health concerns has been found
to significantly increase visit duration [62].
Providers also may not feel that behavioral health pro-
blems, particularly AOD problems, fall within their pur-
view. A recent survey of pediatricians found that, while
the majority (88%) felt that they should be responsible
for identifying substance abuse among their patients,
very few (21%) felt that they should be responsible for
the treatment and management of those problems, pre-
ferring instead to refer such patients to other providers
for treatment (90%) [63]. This is in spite of the fact that
many primary care providers also express skepticism
about the effectiveness of specialty AOD treatment. One
survey found that only 21% of PCPs believed that inter-
ventions would be effective at least half the time [28].
Other provider factors that may predict screening in-
clude outcome expectancy, concerns about intrusive-
ness, negative attitudes about patients with alcohol
problems, and level of confidence about screening and
intervention skills.
Characteristics such as gender, age, and experience
may also play a role in how well providers identify AOD
use and intervene [64-66]. Some studies have found pro-
vider gender to predict screening practices, with women
PCPs being more likely than men to provide preventive
services, including screening patients for alcohol pro-
blems and using standardized instruments [30,65]. In a
national survey of adolescent patients, Klein and Wilson
found that patients were more likely to report having
discussed health risk behaviors if their doctor was female
[66]. Other studies found that younger providers report
more screening than older ones [30,65], although this
may actually reflect differences in training rather than
age.
Patient demographic characteristics and medical and
psychiatric conditions may also affect the likelihood of
being screened and treated for AOD use, although this
has not been well-studied in adolescents. A US survey of
PCP screening of adults found that most primarily
screen pregnant women and patients suspected of hav-
ing a problem [67]. Gender differences have been found
in how other psychosocial problems are diagnosed
[68,69], and some studies suggest that female patients
are less likely to be screened than male [70-72]. Older
adolescents are more likely to be screened than younger
[73,74].
The barriers to and facilitators of AOD screening have
not been as well-studied in pediatrics as in adult medi-
cine, and they have not been studied in the context of a
health plan with electronic medical records (EMRs),
which may reduce some of the previously reported bar-
riers. This paper describes findings from a study that
explored the approaches of pediatric PCPs to adolescent
AOD screening and intervention in primary care. We
explored factors that might either prompt PCPs to
screen their patients or cause them to refrain from
screening. We examined the prevalence of self-reported
and EMR-recorded adolescent AOD screening in a
population base of PCPs. We assessed the PCP factors
(e.g., demographics, training, knowledge, and attitudes),
patient factors (e.g., age, gender, co-occurring conditions,
and other risk factors), and organizational factors (e.g.,
time constraints, confidentiality policies) that influence
providers’ screening practices. We also examined PCPs’
perceived barriers to screening practices, and what
mechanisms and approaches would facilitate screening.
Finally, we examined PCP practices when adolescent
AOD problems are identified. Findings could shed light
on solutions to the persistent obstacles faced by those
seeking to implement screening and brief intervention
for AOD problems of adolescents in medical settings.
Methods
Setting
The study was conducted in the Kaiser Permanente
Northern California (KPNC) health-care system; a large
integrated health care delivery system serving over 3.4
million members (about 34% of the commercially
insured population of the Northern California region),
with approximately 450,000 members between ages 11
and 21. Kaiser Permanente Northern California has 48
medical facilities and employs approximately 607 pedia-
tricians. In general, the membership is working- and
middle-class, although several counties have contracted
with KPNC to serve their Medicaid patients. The KPNC
system provides integrated AOD and psychiatry services.
Sample and procedures
The sample consisted of all KPNC PCPs based in
pediatric or family practice departments who had at least
50 adolescents currently on their panel (N = 540). A
Sterling et al. Addiction Science & Clinical Practice 2012, 7:13 Page 4 of 12
http://www.ascpjournal.org/content/7/1/13
provider’s “panel” consists of all members for whom the
provider is the PCP.
Eligible providers were contacted via e-mail about an
online survey and were invited to participate. The e-mail
contained a hyperlink to the survey. All KPNC providers
have access to e-mail and the organization’s intranet on
the computers located in their offices; most also have ac-
cess at home and the ability to read e-mail at their leis-
ure. The survey software allowed participants to start
and stop as desired. Passive consent was assumed if
PCPs chose to access the survey, and they were offered a
$50 gift certificate to reimburse them for their time. E-
mail reminders were sent to nonresponders. After two
reminders, research staff contacted the participant to ad-
minister the interview via telephone or to set up an in-
person interview. Survey data were captured on a secure
server at the Kaiser Permanente Division of Research
and stored on password-protected computers. The study
received approval from the Institutional Review Boards




The survey included four main sections: provider, pa-
tient, and organizational factors impacting AOD screen-
ing and provider screening practices.
Provider factors
We measured PCP age, gender, and ethnicity; medical
specialty (general pediatrics, adolescent medicine); and
years of experience (less than 10 or ≥10). We asked par-
ticipants about the extent of their recent AOD training
(training within the past 5 years versus none) and
whether they felt satisfied with continuing medical edu-
cation opportunities to stay current on issues of AOD
and mental health problems in adolescents.
We examined levels of comfort with, and perceived ex-
pertise in, adolescent behavioral health problems by ask-
ing participants how difficult they felt it was to discuss
alcohol abuse, drug abuse, depression, and risky sexual
practices with their patients. They were asked how pre-
pared they felt to diagnose patients with alcohol,
marijuana, other illicit drug, and prescription drug pro-
blems and/or depression. The four questions related to
readiness to diagnose AOD problems were combined to
create a “prepared to diagnose” AOD composite score.
These questions were first dichotomized (prepared ver-
sus not prepared to diagnose) and then summed to cre-
ate a score ranging from 0 to 4 indicating the providers’
level of comfort in diagnosing AOD disorders (4 = very
prepared). We also asked providers to what extent they
felt knowledgeable about AOD use trends among
adolescents and their opinion about the effectiveness of
AOD specialty treatment.
Patient factors
These questions related to patient characteristics that
were most likely to prompt PCPs to screen and address
AOD problems. We asked participants if they were more
likely to screen boys versus girls or older versus younger
adolescents and which ethnic groups have higher rates
of AOD problems. Potential warning signs (e.g., school
problems, depression, legal problems, family conflict,
parental AOD abuse, unusual sleeping patterns, and
weight loss) that would prompt them to screen for AOD
use were also examined. Regarding the types of sub-
stances their patients were using, the PCPs were asked
which substances were most frequently misused among
patients with AOD problems and which substance they
felt posed the greatest risk to their patients. We also
asked them to rank, in order of importance, the health
conditions or risk factors for which their patients should
be screened.
Organizational factors
We measured the organizational factors that PCPs felt
were either barriers to or facilitators of adolescent AOD
screening and treatment, such as time constraints, confi-
dentiality issues, referral and treatment resources, prox-
imity to mental health and AOD treatment, and
perceptions as to which staff are best equipped to deliver
such services. We asked them the reasons why they
might refrain from discussing AOD use with their
patients and what it would take to consistently screen
every adolescent for substance use. We also asked
whether they felt that organizational policies and state
laws about confidential adolescent health services pre-
sented barriers to discussing AOD use with their
patients.
Provider self-reported screening practices
Providers were asked to estimate both how often they
screened their adolescent well-visit patients for AOD
use and the percentage of adolescent well-visit patients
they screened for the following: alcohol, drugs, tobacco,
friends' AOD use, and riding in a car when the driver
had used AOD. We asked whether, in addition to the
AOD measures in the electronic medical record (EMR),
they used standardized, evidence-based AOD screening
instruments to assess their patients’AOD use. They were
asked about their usual practice if they suspected a pa-
tient had an AOD problem; i.e., whether they were likely
to counsel patients themselves or refer them to someone
else, and if the latter, to whom or what department were
they likely to refer.
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Electronic medical records
The KPNC network maintains its own EMR system,
which integrates clinical and diagnostic data with
appointments, registration, and billing for each en-
counter. Diagnoses and procedures are coded accord-
ing to both ICD-9-CM and CPT4 classification
systems. The records also include information from
other data sources such as patient questionnaires filled
out by clinicians. The “Teen Well Check” template is
an integral part of every adolescent’s electronic chart.
It records the results of physical exams and is the offi-
cial documentation template for every adolescent well-
visit. The template includes the “Teen Well Check
Questionnaire,” a comprehensive checklist comprised
of questions on a variety of health behaviors, including
alcohol use (past year), marijuana and other drug use
(ever), tobacco use (past year), close friends using
AOD, driving with a driver who has used AOD, de-
pression, and suicidality. The questionnaire is part of
the standard recommended workflow for all adolescent
well-visits within the KPNC health system and is com-
pleted by the adolescent prior to seeing the PCP for
his or her physical exam.
We examined EMR data for each provider who partici-
pated in the study. The mean panel age for each pro-
vider was calculated. EMR-recorded screening rates
were also calculated. Screening rates for each provider
were defined as the percentage of the total number of
adolescent patients who presented for a teen well-visit
who were then screened for behavioral health problems.
Screening was defined as the PCP having completed the
Teen Well Check Questionnaire set of AOD-related
questions.
Analysis
Basic frequencies and Pearson chi-square tests were
used to describe the provider, patient, and organizational
factors associated with screening. Paired t-tests were
used to analyze differences in self-reported and EMR-
recorded screening rates. Of the 437 providers who
responded to the survey, 397 had at least one teen with
a well-visit in the six months prior to the survey. The
EMR-recorded screening rates were based on these vis-
its. We built multivariable logistic regression models to
examine the independent effects upon screening rates of
average panel age, preparedness to diagnosis AOD pro-
blems composite score (0–3), and three barriers to
screening: time constraints, concerns about adolescent
confidentiality, and being uncertain that treatment is ef-
fective. Both self-reported and EMR-recorded screening
rates were modeled. All analyses were conducted using
SAS/STATW software version 9.2 (SAS Institute, Inc.,
Cary, NC).
Results
The web-based survey had an 81% response rate
(N= 437). The mean age of PCPs in the sample was 45;
53% were white, 34% were Asian, 9% were Hispanic, and
4% were African American; 60% were female. The aver-
age age of patients in the PCPs’ panels was 14.5. The
mean time since training was 17 years.
Provider factors
PCPs reported that several factors influenced screening
practices, including limited AOD screening and treat-
ment knowledge and low self-efficacy/high sensitivity
about addressing AOD problems, particularly compared
with other behavioral problems. Nineteen percent of the
PCPs reported that it was “difficult” or “very difficult” to
discuss alcohol abuse with their patients; 22% found it
difficult to discuss drug use, and 15% found it difficult to
discuss depression (Table 1). Only 1% felt “not at all
comfortable” discussing risky sexual practices with their
patients. Many PCPs felt unprepared to diagnose AOD
problems: 42% felt unprepared to diagnose alcohol pro-
blems, 37% felt unprepared to diagnose marijuana pro-
blems, and 56% felt unprepared to diagnose other illicit
drug or prescription drug problems. In contrast, only
29% felt unprepared to diagnose depression among their
patients (Table 2). Thirty percent reported that they did
not discuss AOD use with their patients because
“patients don’t tell the truth” about AOD use; 6% did
not discuss it because they did not want “to frighten or
anger” patients, and 5% did not discuss it because they
might be seen as “questioning patients’ integrity.” Four-
teen percent said that feeling “uncomfortable talking
Table 1 Factors Influencing Screening
Percent of Providers (N= 437) p-value
Difficult to discuss with patients:
Drug abuse 22
Alcohol abuse 19





Depression 29 < 0.001





Alcohol use 40 < 0.001
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about AOD abuse” would prevent them from discussing
AOD use with their patients (Table 2).
Although only 14% reported receiving no instruction
on AOD problems at all in the past five years, 48% were
satisfied they were staying current on AOD problems
and treatment. Over half the sample (52%) felt that
AOD treatment was either not very, or not at all, effect-
ive. Those PCPs with <10 years of experience said they
were less likely to talk to their patients about AOD use
because of uncertainty about AOD treatment effective-
ness, compared with those with more experience (32%
versus 20%). Fewer female PCPs said that treatment was
effective (25% versus 33%), and more reported that con-
fidentiality was a barrier to discussing AOD use with
their patients (35% versus 27%).
Patient factors
There was variation as to which patients PCPs were
most likely to screen and what conditions and risk beha-
viors prompted screening. Thirteen percent of PCPs
reported being more likely to screen boys than girls, and
male PCPs were even more likely than females to report
that they were more apt to screen boys than girls (23%
versus 6%, p < 0.0001). They reported perceptions of dif-
ferences in the rates of AOD problems by ethnicity; e.g.,
39% said that white adolescents had higher rates of
AOD problems, followed by African Americans (37%),
Hispanics (35%), Native Americans (14%), Pacific Islan-
ders (6%), and Asians (4%). Sixty-two percent of PCPs
said they were more likely to screen older than younger
adolescents. In order of importance, the conditions they
reported would trigger AOD screening were depression
(94%), school problems (93%), weight loss (78%), sleep-
ing problems (75%), family conflict (71%), and anxiety
(71%). Eighty-six percent felt that AOD use was related
to psychiatric comorbidity. When PCPs were asked to
rank what they considered to be the most pressing con-
ditions and risk factors to screen their patients for, alco-
hol use was ranked the fifth most serious risk; the other
four were: 1) nutrition, 2) STDs, 3) exercise, and 4) de-
pression (Table 1).
When asked which substances were more frequently
misused among patients with an AOD problem, respon-
dents reported alcohol (89%), marijuana (88%), party
drugs (20%), methamphetamines (14%), prescription opi-
ates (8 %), cocaine (7%), and inhalants (1%). They ranked
the substances they considered most risky for their
patients to use as heroin (90%), methamphetamine
(86%), cocaine (85%), prescription opiates (75%), inha-
lants (74%), party drugs (72%), alcohol (28%), and
marijuana (25%).
Organizational factors
Eighty percent of respondents reported that time con-
straints would cause them to avoid discussing AOD use
with patients, making it the number one barrier. Other
reported barriers to screening were feeling that they did
not “have sufficient information about referral options”
(12%), and the fear that documentation of AOD use in
medical record could adversely affect patients (9%).
Many of the PCPs (32%) perceived adolescent confiden-
tiality policies and regulations as a barrier to discussing
AOD use and problems. The major facilitators they sug-
gested for consistent screening were extra time (76%),
using other providers to screen (56%), and having
screening done prior to seeing the patient (51%)
(Table 2).
Provider self-reported screening rates and EMR-recorded
screening rates
Only 5% of the PCPs reported using standardized
evidence-based AOD screening instruments to assess
patients’ AOD use. If they suspected a patient had an
AOD problem, 93% reported they would refer them to
someone or somewhere else for treatment, 91% reported
that they would counsel the patient on the dangers of
AOD use, and 42% said they would provide educational
materials. Seventy-four percent said they would refer
patients with AOD problems to mental health treatment,
while 61% said they would refer them to specialty AOD
treatment. We examined PCPs’ EMR-recorded screening
rates among adolescents who had a well-child visit with
them in the prior 6 months and found their self-
reported screening rates were significantly higher than
their EMR-recorded rates for all substances: alcohol
(92% reported versus 65% EMR, p < 0.001); drugs (88%






Patients do not tell the truth 30
Uncertain treatment is effective 24
Uncomfortable talking about AOD use 14
Did not have sufficient information about
referral options
12
Documentation of AOD in medical record
could adversely affect patient
9
Do not want to frighten or anger patient 6
Questions patient's integrity 5
Facilitators: % Endorsing
Extra time 76
Having an MA screen or clinician to review results 56
Having the screening done prior to seeing patient 51
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versus 64%, p < 0.001); and tobacco (92% versus 64%,
p < 0.001) (Table 3).
Independent predictors of self-reported and EMR-
recorded screening
Participants who felt prepared to diagnose AOD pro-
blems were more likely to have higher self-reported
screening rates (OR= 1.02, 95% CI = 1.01-1.03), while
those who identified time constraints as a screening bar-
rier were less likely to have higher self-reported AOD
screening rates (OR= 0.91, 95% CI = 0.88-0.94). Con-
cerns about confidentiality and uncertainty that treat-
ment is effective were not significantly associated with
self-reported screening rates. Those PCPs with an older
average panel age were more likely to have higher EMR-
recorded AOD screening rates (OR= 1.11, 95% CI =
1.07-1.16). (Table 4).
Discussion
As other studies have found [31,32], PCPs’ knowledge
about AOD screening and treatment techniques, their
self-efficacy in regard to addressing AOD use, and their
discomfort with discussing AOD use were each identi-
fied as factors influencing screening practices. Results
suggest they feel less prepared to diagnose alcohol than
depression, they rate alcohol as more difficult to discuss
than depression, and they are more comfortable talking
about sexual practices than alcohol. Nineteen percent
reported alcohol as being “difficult to discuss,” whereas
only 1% reported “feeling uncomfortable” discussing
risky sexual practices. Sensitivity about discussing AOD
use has been cited as a barrier to screening among adult
patient populations [75] because providers fear alienat-
ing patients or are hesitant to criticize culturally sanc-
tioned behavior (drinking alcohol and, increasingly in
some states, using marijuana). However, our findings
suggest PCPs find alcohol and drugs difficult to discuss
with adolescent patients even when their use is neither
sanctioned nor legal. Training to destigmatize these
topics and to increase PCP confidence and self-efficacy
about discussing drinking and drug use would help ad-
dress these problems. As found in other research, how-
ever [76], fewer opportunities for education about
adolescent AOD use and assessment and treatment are
available than providers would like; less than half were
satisfied that they were staying current on AOD-related
health topics. Fortunately, several new US training
grants and medical school loan repayment programs tar-
get AOD screening and treatment education for PCPs,
emphasizing the integration of mental and physical
health and the treatment of vulnerable groups such as
those with AOD problems [77]. Moreover, many organi-
zations, including the American Academy of Pediatrics
and the Substance Abuse and Mental Health Services
Administration (SAMHSA), have initiatives to increase
screening for adolescents, improve the environment for
addressing alcohol as part of health care (as with smok-
ing), and facilitate provider familiarity with AOD use
and problems [17].
Patient characteristics also influenced attitudes to-
wards screening. The majority of PCPs said they were
more likely to screen boys than girls and were more
likely to screen older than younger patients. They also
felt that teens of different ethnic groups had different
rates of AOD problems, with white, African American,
and Hispanic youth perceived as having higher rates of
use than other ethnic groups. The PCPs surveyed in this
study clearly recognized the role of psychiatric comor-
bidity; 86% saw it as related to AOD problems. Depres-
sion was reported to be the most salient trigger for
AOD screening, followed by school problems, weight
loss, sleeping problems, family conflict, and anxiety. The
providers ranked alcohol as only the fifth most pressing
risk factor warranting screening, after nutrition, STDs,
exercise, and depression; drug use did not make the top
five risk factors. All these conditions and behaviors are
compelling risk factors in adolescent health; thus, PCPs
must balance a multitude of competing priorities in a
visit [59].
As other studies have found [10], time constraints
emerged as an important barrier to screening. The pres-
ence of an EMR to help standardize procedures and
instruments did not obviate that key issue. Other factors,
such as uncertainty about AOD treatment effectiveness,
concerns about the potentially detrimental effect of such
discussions on the provider-patient relationship, and
Table 3 Provider Self-Reported and EMR-Recorded Screening Rates
Self-Reported Rates (N = 437) EMR-Recorded Rates (n = 397)* p-value
Screening Questions Asked:
Alcohol 92% 65% <0.001
Drugs 88% 65% <0.001
Tobacco 92% 66% <0.001
Friends' alcohol and drug use 76% 66% <0.001
In a car when driver used alcohol and/or drugs 47% 66% <0.001
*Of the 437 providers who responded to the survey, 397 had a Teen Well Check visit in the six months prior to the survey from which the EMR rates are based.
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discomfort discussing AOD issues were identified as sig-
nificant barriers by fewer PCPs. One-third of the PCPs
cited confidentiality as a barrier to screening; they strug-
gle with the challenges involved in addressing AOD pro-
blems within the context of a confidential adolescent
visit, balancing the need to maintain a relationship of
trust with their patients, and the occasional need to
break confidentiality and reveal AOD use to parents,
particularly when problems may be severe enough to
warrant referral to specialty treatment.
We found few independent predictors of screening, ei-
ther self-reported or EMR-recorded. Those PCPs with
panels of higher average patient age had higher EMR-
recorded screening rates, while those who reported
being more prepared to diagnose AOD problems had
higher odds of increased self-reported rates, and those
who endorsed time constraints as a barrier to screening
were more likely to have lower self-reported screening
rates. The discrepancy between self-reported and EMR
screening rates is troubling but not unexpected; other
research has found over-reporting of preventive clinical
activities related to similarly “sensitive” topics [78]. The
less-than-optimal EMR-recorded rates suggest that, even
with systematic screening, an AOD screening tool em-
bedded in a health system’s EMR, and standardized
workflow, more effort is needed to ensure that AOD
screening is a component of all adolescent well visits
(and all nonemergency visits, many would argue). Con-
versely, the fact that nearly two-thirds of all teens are
being screened during well visits, a higher rate than that
found in other studies [24], suggests the value of system-
level strategies to facilitate screening. These findings,
coupled with reports from PCPs that AOD knowledge
and self-efficacy as well as organizational issues such as
time limitations and staffing influenced their screening
practices, suggest the benefits of exploring a model of
systematic screening that employs both standardized
evidence-based screening instruments and clinicians
trained in AOD screening and assessment.
Based on the survey findings, we conducted a pilot
study of adolescent screening, brief intervention, and re-
ferral to treatment (SBIRT) in a large general pediatric
clinic within the KPNC health system. The intervention
sought to address organizational barriers identified in
the survey, such as PCPs’ well-founded concerns about
the additional time required to address behavioral pro-
blems in time-limited well-visits [62] and about having
other personnel conduct the screening and intervention
(if needed). At the same time, it addressed, directly or
indirectly, some of the more complex provider-level fac-
tors that could impede screening (for example, low levels
of self-efficacy and high levels of discomfort about dis-
cussing AOD problems) and allowed for referral for
broader behavioral health problems.
Compared with usual care, which does not provide for-
mal “in-house” behavioral health services in general
pediatrics departments, this pilot intervention provided as
a resource to the PCPs a behavioral clinician trained in
motivational interviewing and brief intervention. The pilot
took advantage of the Teen Well Check AOD use ques-
tions included in the health system’s EMR to use as “trig-
ger” questions for identifying patients at risk and provided
brief training to PCPs on the need for systematic AOD
screening and on the process for referring teens to the be-
havioral clinician. This intervention encouraged a more
systematic approach, indirectly addressing the self-
reported tendency of PCPs to screen by gender, age, sub-
stance type, or other characteristics. Sessions of SBIRT
included further screening; brief interventions for sub-
stance use, depression, anxiety, and other behavioral risk
behaviors for patients with lower-severity AOD problems;
and clinician-facilitated referral and follow-up to specialty
AOD and mental health treatment as needed for patients
with higher-severity AOD or mental health problems. To
assess whether the intervention resulted in more screen-
ing and intervention, we used the EMR to compare pre-
and post-intervention rates of screening and brief inter-
vention and AOD and mental health visits. Rates of
behavioral-health treatment utilization increased during
the pilot; for adolescents with routine well-child visits,
specialty behavioral health treatment initiation increased
from 8.7% to 12.0% (p< 0.0001). Although the findings
from this small pilot cannot be interpreted as causal, and
the project did not have the resources to address many of
Table 4 Self-Reported and EMR-Recorded Screening Logistic Regression Models
Self-Reported Rates (N= 437) EMR-Recorded Rates (n = 397)*
OR CI OR CI
Average panel age 1.01 0.98-1.05 1.11** 1.07-1.16
Prepared to diagnose AOD composite score 1.02** 1.01-1.03 1.00 0.99-1.01
Time constraints as barrier (yes versus no) 0.91** 0.88-0.94 1.01 0.97-1.05
“Uncertain treatment is effective” as barrier (yes versus no) 1.00 0.98-1.03 0.99 0.96-1.01
Confidentiality as barrier (yes versus no) 1.03 1.00-1.06 0.98 0.94-1.01
*Of the 437 providers who responded to the survey, 397 had a Teen Well Check visit in the six months prior to the survey from which the EMR rates are based
**p < 0.001.
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the provider and patient factors identified in the survey as
influencing screening practices, the results suggest ways to
increase screening for, and treatment of, adolescent AOD
problems in pediatric primary care settings. Further re-
search on interventions designed to address provider-level
factors that inhibit screening would be beneficial; specific-
ally, enhanced medical and continuing education training
on AOD screening and brief intervention and the devel-
opment of streamlined, provider-friendly instruments and
workflows to address adolescent AOD problems.
Because adolescent AOD problems frequently co-
occur with other medical and mental health conditions
[15,16], and these adolescents are costly consumers of
health services [79], the early identification and preven-
tion of AOD problems should be of great interest to
policy-makers and health-care systems. Under health-
care reform legislation, many health systems are now
required to retain members into young adulthood. Fu-
ture studies should continue to test models of care that
can deliver AOD and behavioral health services effi-
ciently and cost-effectively and in a manner to which
providers will be amenable.
This study was conducted in a private-sector inte-
grated health system with a relatively mature EMR con-
taining a behavioral health screener. As such, results
may not be generalizable to other health systems. How-
ever, systems such as KPNC’s have increasingly become
a major organizational model for private and public
health care, including many state Medicaid systems.
Fundamental changes are occurring that provide an in-
centive to integrate behavioral health into primary care
in the US in both public and private settings. These in-
clude health reform and parity legislation and a substan-
tial increase in federal funding flowing to safety net
providers such as federally qualified health centers
(FQHCs) and community health centers to promote the
integration of behavioral health services and training
and the implementation of EMR [77]. In the coming
decade, over half of patients newly insured under health-
care reform will be insured through Medicaid with the
Children’s Health Insurance Program (CHIP) rolled into
it [80], most of whom will receive services in private
health systems and FQHCs. Our findings on barriers
and facilitators of AOD screening of adolescents in pri-
mary care and the potential effectiveness of a systematic
adolescent SBIRT model may help to inform this trans-
formation of primary care practice.
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